Figure 4.

Structure-binding activity relationships discovered for 1-aryl-2-aminobenzimidazoles targeting the HCV IRES subdomain IIa RNA.

Structure-binding activity relationships discovered for 1-aryl-2-aminobenzimidazoles targeting the HCV IRES subdomain IIa RNA.